Results 101 to 110 of about 393,653 (192)

Development of nanoparticle-based Toll-like receptor agonists for respiratory immunotherapy. [PDF]

EXCLI J
Raikar AS, Verma A, Naik MB, Prabhu SM, Paudel KR, Dua K.   +5 more
europepmc   +1 more source

Author Correction: Toll-like receptor 5 on monocyte as a biomarker of mortality risk in patients with sepsis. [PDF]

BMC Infect Dis
Tan H, Wang H, Zhou X, Que W, Yang X.
europepmc   +1 more source

Different toll like receptor (TLR) expression patterns in progression towards cancer

Frontiers in Immunology, 2014
Lauri eJouhi, Suvi eRenkonen, Timo eAtula, Antti eMäkitie, Caj eHaglund, Jaana eHagström   +5 more
doaj   +1 more source

HMGB1 binds to and disrupts the hairpin structure of RNA15 and inhibits toll-like receptor activation. [PDF]

J Biol Chem
Lin C, Li P, Savitskaya AG, Lyukmanova E, Goncharuk SA, Mineev KS, Du X, Wang Y, Wang X.   +8 more
europepmc   +1 more source

Toll-Like Receptor Pathways in Autoimmune Diseases [PDF]

, 2019
Chen, Ji-Qing, Szodoray, Péter, Zeher, Margit   +2 more
core  

Toll-like Receptor 7 Deficiency Attenuates Platelet Dysfunction in Sepsis. [PDF]

Biomolecules
Mohamed-Hinds R, Dutta A, Park C, Yang X, Zou L, Chao W, Williams B.   +6 more
europepmc   +1 more source

Negative Regulator of Interferon Response Promotes Toll-like Receptor 3-induced Interleukin 6 in Rheumatoid Synoviocyte. [PDF]

In Vivo
Wada K, Imaizumi T, Ishibashi HK, Nakamura Y, Saruga T, Kawaguchi S, Tachizaki M, Oishi K, Sasaki E, Wada K, Ishibashi Y.   +10 more
europepmc   +1 more source

Phosphoproteomic profiling of lipopolysaccharide stimulated toll-like receptor pathways in macrophages. [PDF]

Sci Data
Kim D, Yoon SH, Manes NP, Nita-Lazar A.
europepmc   +1 more source

Updates on Toll-Like Receptor 10 Research. [PDF]

Eur J Immunol
Riva F, Muzio M.
europepmc   +1 more source

Toll-like Receptor 7/8 Agonists Exert Antitumor Effect in a Mouse Melanoma Model. [PDF]

Medicina (Kaunas)
Isvoranu G, Surcel M, Enciu AM, Munteanu AN, Neagu M, Niculae AM, Chiritoiu G, Munteanu CVA, Chiritoiu-Butnaru M.   +8 more
europepmc   +1 more source